Indication

Plasminogen deficiency type 1

Plasminogen deficiency type 1, also known as hypoplasminogenemia, is an ultrarare autosomal recessive multisystem disorder caused by mutations in the *PLG* gene. Read more about Plasminogen deficiency type 1

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Plasminogen deficiency type 1 therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Plasminogen deficiency type 1 preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Plasminogen deficiency type 1.

Plasminogen deficiency type 1, also known as hypoplasminogenemia, is an ultrarare autosomal recessive multisystem disorder caused by mutations in the *PLG* gene.

It is characterized pathophysiologically by markedly reduced levels of both immunoreactive plasminogen antigen and functional plasminogen activity, leading to severely impaired extracellular fibrinolysis and inadequate wound healing.

Clinically, this defect results in the spontaneous or trauma-induced accumulation of fibrin and chronic inflammation across mucosal membranes, producing dense, "woody" pseudomembranous lesions.

While ligneous conjunctivitis is the most hallmark presentation and can lead to corneal scarring and vision loss, lesions frequently compromise the respiratory tract, oral cavity, gastrointestinal tract, and genitourinary system.

Personalize your experience

Follow Plasminogen deficiency type 1 and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it